AIM ImmunoTech (AIM) Amortization of Deferred Charges (2017 - 2024)
AIM ImmunoTech's (AIM) quarterly Amortization of Deferred Charges came in at $69000.0 in Q4 2024, up 281.58% on a QoQ basis from -$38000.0 in Q3 2024.
AIM ImmunoTech (AIM) Amortization of Deferred Charges (2017 - 2024) Analysis & Trends
AIM ImmunoTech (AIM) has 6 years of Amortization of Deferred Charges data on file, last reported at $69000.0 in Q4 2024.
- Quarterly Amortization of Deferred Charges changed N/A year-over-year to $69000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $301000.0 (changed N/A YoY) and the FY2025 annual result came in at $552000.0, up 83.39% from the prior year.
- Amortization of Deferred Charges rose to $69000.0 in Q4 2024, from -$38000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $197000.0 in Q2 2024 to a low of -$139000.0 in Q2 2020.
- A 3-year average of $46000.0 and a median of $35500.0 in 2020 frame the typical range for Amortization of Deferred Charges.
- The widest YoY moves for Amortization of Deferred Charges: up 417.14% in 2020, down 486.11% in 2020.
- Tracing AIM's Amortization of Deferred Charges over 3 years: stood at $35000.0 in 2020, then sank by 68.57% to $11000.0 in 2021, then surged by 527.27% to $69000.0 in 2024.
- The last three Amortization of Deferred Charges figures came in at $69000.0 (Q4 2024), -$38000.0 (Q3 2024), and $197000.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | AIM ImmunoTech | 4.43 Mn | -5.53 Mn | 21,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 69,000.00 |
| Dec 31, 2024 | 69,000.00 |
| Sep 30, 2024 | -38,000.00 |
| Sep 30, 2024 | -38,000.00 |
| Jun 30, 2024 | 197,000.00 |
| Jun 30, 2024 | 197,000.00 |
| Mar 31, 2024 | 73,000.00 |
| Mar 31, 2024 | 73,000.00 |
| Jun 30, 2021 | 11,000.00 |
| Jun 30, 2021 | 11,000.00 |
| Mar 31, 2021 | 36,000.00 |
| Mar 31, 2021 | 36,000.00 |
| Dec 31, 2020 | 35,000.00 |
| Dec 31, 2020 | 35,000.00 |
| Sep 30, 2020 | 35,000.00 |
| Sep 30, 2020 | 35,000.00 |
| Jun 30, 2020 | -139,000.00 |
| Jun 30, 2020 | -139,000.00 |
| Mar 31, 2020 | 181,000.00 |
| Mar 31, 2020 | 181,000.00 |